You are here
Global Institutions and Partnerships
Pfizer's efforts to help build healthcare capacity and expand access to medicines would not be possible without our partnerships with nongovernmental organizations (NGOs), governments, and foundations. An important part of Pfizer’s partnership starategy is to focus on building and advancing relationships with large international organizations, civil societies, and foundations to help ensure communities in need get the healthcare they deserve.
Our strategy regarding global stakeholders and institutions is to focus on finding common objectives to advance public health and building programs that create solutions for communities in need.
We are also committed to the transparency and accountability of our programs, and aim to report on significant activities for a wide array of external stakeholders, including socially responsible investors and analysts.
Pfizer Corporate Responsibility has a strong tradition of working with multilateral organizations, NGOs, and civil society organizations to help develop and deliver the interventions and information that cover global health issue-areas including active and healthy aging, non-communicable diseases, and access to medicines.
In addition to working with partners directly on issues regarding access, we work with various organizations based in Geneva and around the world to help inform governments and multilateral organizations and shape positive global health and policy environments for the industry. Multilateral organizations have significant influence in the global health field and can open opportunities or impose challenges and obstacles.
For example, we connect Pfizer colleagues with multilateral organizations like the World Health Organization and global NGOs to proactively share insights, knowledge, and best practices, and to identify and communicate areas for shared investment and collaboration around global health issues.
Building Programs That Create Solutions
Pfizer is committed to advancing collaborative efforts to reduce the morbidity and mortality associated with a wide range of chronic diseases for people across their life-course, and to help them achieve a healthy life at all ages. Non-communicable diseases (NCDs) are the leading cause of death and disability globally, and, along with infectious diseases, are contributing to a double-disease burden in people of all ages in low-, middle-, and high-income countries. Pfizer actively partners with organizations to implement cost-effective interventions designed to prevent and control NCDs.
A recent example is Pfizer’s partnership with HelpAge International. Since 2012, Pfizer and HelpAge International have worked together to enhance access to health services related to NCDs among older people in Tanzania, particularly to address chronic conditions. The initiative involves support for organizations that help older people overcome myriad barriers to access in Tanzania’s health system. The project was expanded to focus on developing health messaging through an intergenerational approach. This project also encompasses initiatives aimed at improving data collection and analysis to inform appropriate policies.
Reporting Key Performance Indicators
Using our broad knowledge across many areas of global interest, Pfizer Corporate Responsibility serves as a primary resource for responding to inquiries from Pfizer’s Socially Responsible Investors (SRIs). We also apply our expertise in analysis of global trends and healthcare data to overseeing the production of Pfizer’s Annual Review.